Clinical Trials Logo

Clinical Trial Summary

This study seeks to compare patients with vasomotor rhinitis ("perennial nonallergic rhinitis," "idiopathic rhinitis") with normal controls with respect to their nasal physiologic reactivity to cold air challenge. Ten vasomotor rhinitis (VMR) patients with nasal symptoms triggered predominantly by cold air, four VMR patients with symptoms triggered predominantly by chemicals, and ten nonallergic, non-rhinitic control subjects will be studied.


Clinical Trial Description

After initial screening and verification that subjects can cooperate with active posterior rhinomanometry, subjects will be scheduled for two 15-minute exposure sessions with either: cold-dry air, or warm-moist air. Subjects will rate symptoms (and have their nasal airway resistance measured in triplicate) prior to exposure and at 15-min. intervals post-exposure until an hour has passed. ;


Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT00415493
Study type Interventional
Source Associated Scientists to Help Minimize Allergies
Contact
Status Completed
Phase N/A
Start date December 2006
Completion date May 2008

See also
  Status Clinical Trial Phase
Completed NCT00979615 - Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis Phase 4
Completed NCT01509209 - Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis Phase 3
Completed NCT00745849 - Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial N/A
Recruiting NCT05348148 - Comparison of the Effects for Lightening the Shiners Among Different Treatments for Rhinitis N/A
Completed NCT00118703 - Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis Phase 3
Completed NCT00682162 - Impact of Acupuncture on Vasomotor Rhinitis Phase 3
Completed NCT00976209 - Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED) Phase 3